KLOW 10 mg Vial
KLOW
Proprietary Multi-Peptide Research Blend
Peptide Name: KLOWBlend Type: Proprietary Research BlendChemical Name: Multi-Peptide Complex containing BPC-157, TB-500, GHK-Cu, and KPVCAS Number: N/A for blendComponent CAS Numbers:BPC-157: 137525-51-0TB-500 / Thymosin β4 fragment: 75591-33-4GHK-Cu: 89030-95-5KPV: 67727-97-3
Researched Areas & Benefits
KLOW has been developed as a premium animal-focused research blend, with a strong emphasis on equine tissue recovery, tendon and ligament repair models, inflammation control, vascular support, and collagen remodeling.
Key researched areas include:
Inflammation control to help stabilize the repair environmentAngiogenesis support for improved blood-flow researchCollagen remodeling and connective-tissue qualitySystemic tissue recovery supportMast-cell and immune-response modulationMusculoskeletal recovery research in high-performance animalsTendon, ligament, joint, and soft-tissue repair pathways
Product Description
KLOW is a proprietary multi-peptide research blend designed for advanced animal peptide research, with particular relevance to horses, performance animals, and small-animal recovery models. The formula combines four well-researched peptide compounds — BPC-157, TB-500, GHK-Cu, and KPV — each selected for its role in different stages of the tissue-repair and recovery cascade.
In equine research, recovery is rarely a single-pathway process. Tendons, ligaments, joints, fascia, muscle tissue, and connective structures rely on a coordinated biological environment involving inflammation regulation, blood-vessel formation, fibroblast activity, collagen organization, and immune balance. KLOW was designed around this multi-pathway concept.
The blend is particularly suited to research involving horses because equine athletes place extreme load on tendons, ligaments, joints, and soft tissue. In research models, compounds such as BPC-157 and Thymosin β4 have been associated with tissue-repair signaling, angiogenesis, fibroblast migration, and wound-repair pathways, while GHK-Cu has been studied for collagen remodeling, gene-expression support, and extracellular-matrix regulation. KPV adds an important inflammation-control component, with published research describing anti-inflammatory and antimicrobial activity.
Why KLOW Is Different
Unlike single-peptide research products, KLOW combines multiple mechanisms into one advanced research blend. This makes it an excellent option for researchers studying broad recovery pathways rather than isolated biological effects.
BPC-157 is included for its strong body of animal-model research involving tendon, ligament, muscle, and gastrointestinal tissue repair. A tendon-healing study reported that BPC-157 enhanced tendon fibroblast outgrowth and supported tendon repair mechanisms, making it highly relevant to equine connective-tissue research.
TB-500 / Thymosin β4 is included for angiogenesis and cell-migration research. Published studies have reported that Thymosin β4 promotes angiogenesis, wound repair, and tissue regeneration in animal models, which is especially relevant where blood flow to dense connective tissue is limited.
GHK-Cu is included for collagen and extracellular-matrix research. A major review in International Journal of Molecular Sciences describes GHK-Cu as having regenerative and protective actions, including effects on gene expression, tissue remodeling, and repair-associated pathways.
KPV is included for inflammation-control research. KPV, a C-terminal fragment of alpha-MSH, has been studied for anti-inflammatory activity, antimicrobial properties, and its ability to reduce inflammatory signaling in experimental models.
Horse-Biased Research Positioning
KLOW is especially well positioned for equine research because horses commonly experience high mechanical stress across:
Tendons and ligamentsJoints and cartilage-support structuresMuscles and fasciaHoof-related soft tissuePost-exercise recovery pathwaysInflammation-heavy repair environmentsVascularly limited connective tissues
In simple terms, KLOW is designed for researchers looking at better recovery environments, improved tissue-quality pathways, and stronger biological repair signaling in animal models.
For horse-focused research, the value of KLOW lies in its combined approach:control the inflammatory environment, support vascular signaling, encourage collagen remodeling, and study systemic recovery pathways together.
Kit Includes
1 × KLOW peptide vial1 × 10 ml sterile water1 × reconstitution kit
Important Research Disclaimer
This product is supplied for research use only.
It is not intended to diagnose, treat, cure, or prevent any disease.It is not registered as a veterinary medicine.It is not for human consumption.It is not for animal consumption unless used strictly within legally permitted research frameworks by qualified professionals.
SAHPRA Disclaimer:This product has not been evaluated by the South African Health Products Regulatory Authority. No therapeutic claims are made. All information provided relates to published scientific research and is intended for research, educational, and laboratory reference purposes only.
Scientific References
BPC-157 and tendon healing
Chang et al. reported that BPC-157 enhanced tendon fibroblast outgrowth and supported healing mechanisms in injured tendon models.
BPC-157 healing properties review
Sikiric et al. reviewed BPC-157’s healing properties across gastrointestinal, muscle, tendon, and ligament research models.
Thymosin β4 and wound repair / angiogenesis
Philp et al. reported that Thymosin β4 promoted angiogenesis and wound repair in normal and aged rodent models.
Thymosin β4 accelerates wound healing
Malinda et al. investigated Thymosin β4 in a rat full-thickness wound model and reported enhanced wound-healing activity.
GHK-Cu regenerative and protective actions
Pickart and Margolina reviewed GHK-Cu’s regenerative, protective, gene-expression, and tissue-remodeling actions.
KPV anti-inflammatory and antimicrobial properties
Luger et al. described alpha-MSH-related peptides, including KPV, as having anti-inflammatory and antimicrobial activity.
KPV and intestinal inflammation signaling
Dalmasso et al. studied KPV uptake and reported anti-inflammatory effects in intestinal epithelial models.
